CompletedPhase 1/2

A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a)

Denmark42 participantsStarted 2014-09

Plain-language summary

A study in males and females with elevated Lp(a) to look at the effects of TA-8995 on Lp(a) levels.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male and female (of non-child bearing potential) subjects with elevated Lp(a) levels Exclusion Criteria: * Clinically significant medical history * Abnormal laboratory results (other than lipid levels) or vital signs * Receiving any other drug therapy

What they're measuring

To evaluate the change from baseline in (Lp(a) levels after 12 weeks of treatment with TA-8995.

Timeframe: 12 weeks

Trial details

NCT IDNCT02241772

SponsorXention Ltd

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2015-01

View on ClinicalTrials.gov More Elevated Lp(a) trials